VKTX vs. IVV
Compare and contrast key facts about Viking Therapeutics, Inc. (VKTX) and iShares Core S&P 500 ETF (IVV).
IVV is a passively managed fund by iShares that tracks the performance of the S&P 500 Index. It was launched on May 15, 2000.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VKTX or IVV.
Key characteristics
| VKTX | IVV | |
|---|---|---|
| YTD Return | 267.97% | 27.13% |
| 1Y Return | 620.84% | 39.88% |
| 3Y Return (Ann) | 119.12% | 10.28% |
| 5Y Return (Ann) | 54.29% | 16.00% |
| Sharpe Ratio | 3.84 | 3.15 |
| Sortino Ratio | 5.07 | 4.20 |
| Omega Ratio | 1.65 | 1.59 |
| Calmar Ratio | 9.38 | 4.62 |
| Martin Ratio | 20.66 | 20.91 |
| Ulcer Index | 28.01% | 1.86% |
| Daily Std Dev | 150.68% | 12.31% |
| Max Drawdown | -90.41% | -55.25% |
| Current Drawdown | -27.53% | 0.00% |
Correlation
The correlation between VKTX and IVV is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
VKTX vs. IVV - Performance Comparison
In the year-to-date period, VKTX achieves a 267.97% return, which is significantly higher than IVV's 27.13% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
VKTX vs. IVV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Viking Therapeutics, Inc. (VKTX) and iShares Core S&P 500 ETF (IVV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
VKTX vs. IVV - Dividend Comparison
VKTX has not paid dividends to shareholders, while IVV's dividend yield for the trailing twelve months is around 1.24%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VKTX Viking Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IVV iShares Core S&P 500 ETF | 1.24% | 1.44% | 1.66% | 1.20% | 1.57% | 1.99% | 2.21% | 1.75% | 2.01% | 2.27% | 1.83% | 1.80% |
Drawdowns
VKTX vs. IVV - Drawdown Comparison
The maximum VKTX drawdown since its inception was -90.41%, which is greater than IVV's maximum drawdown of -55.25%. Use the drawdown chart below to compare losses from any high point for VKTX and IVV. For additional features, visit the drawdowns tool.
Volatility
VKTX vs. IVV - Volatility Comparison
Viking Therapeutics, Inc. (VKTX) has a higher volatility of 27.75% compared to iShares Core S&P 500 ETF (IVV) at 3.95%. This indicates that VKTX's price experiences larger fluctuations and is considered to be riskier than IVV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.